SFTPC and lung carcinoma: The pathogenesis of lung cancer induced by EML4-ALK has been confirmed by evidence, and the rapid development of lung cancer is mainly caused by overexpression of EML4-ALK in type II alveolar epithelial cells through the Clara cell secretory protein (CCSP) or surfactant protein c (SPC) promoter (10, 11).